文献速递心脑血管急症重症综合管理与镇静镇痛

动脉瘤性蛛网膜下腔出血致院外心脏骤停后的神经功能结局:多中心队列研究

Neurological outcomes after out-of-hospital cardiac arrest due to aneurysmal subarachnoid hemorrhage: a multicenter cohort study.
PubMed 文献 · Crit Care · 2026-06-10
一句话结论动脉瘤性蛛网膜下腔出血致院外心脏骤停患者6个月神经功能良好结局率仅4.9%,65.8%在1天内进展为脑死亡。

这项法国12个神经ICU的回顾性多中心队列研究纳入2014至2024年间收治的164例动脉瘤性蛛网膜下腔出血致院外心脏骤停后存活入院的成人患者。6个月时仅8例(4.9%)达到改良Rankin量表≤3的神经功能良好结局,156例(95.1%)结局不良,其中154例死亡。108例(65.8%)在1[1-2]天内进展为脑死亡。惩罚性回归未识别出良好结局的独立预测因素,但瞳孔异常和肾上腺素使用与进展为脑死亡相关。作者认为,经选择的患者可能从积极的神经重症监护中获益,高脑死亡率强调了器官捐献路径的重要性。

要点

  • 动脉瘤性蛛网膜下腔出血致院外心脏骤停后存活入院者6个月神经功能良好结局(mRS≤3)率仅4.9%(8/164),95.1%结局不良(mRS≥4)。
  • 65.8%(108/164)在1[1-2]天内进展为脑死亡,需重视器官捐献评估路径。
  • 所有院前接受抗血小板或抗凝治疗的患者(n=14,8.7%)均结局不良。
  • 存活者中脑室外引流、颅内压监测和血管内动脉瘤治疗更常见,ICU和住院时间更长,但惩罚性回归未确认独立预测因素。
  • 瞳孔异常和肾上腺素使用与进展为脑死亡相关,但未确认与良好结局的独立统计关联。

适用人群与场景

  • 法国12个神经ICU收治的成人患者,2014至2024年间动脉瘤性蛛网膜下腔出血致院外心脏骤停后存活入院者。
  • 共164例患者,中位年龄54[43-62]岁,47.5%为男性。

红旗征与不能漏的情况

  • 院前接受抗血小板或抗凝治疗(n=14,8.7%)的患者均结局不良。
  • 瞳孔异常和肾上腺素使用与进展为脑死亡相关。
  • 65.8%患者在1[1-2]天内进展为脑死亡,需及时评估器官捐献路径。

研究设计与关键结果

  • 研究类型为回顾性多中心队列研究,纳入12个法国神经ICU的164例动脉瘤性蛛网膜下腔出血致院外心脏骤停后存活入院成人患者。
  • 主要结局:6个月神经功能良好(mRS≤3)仅8例(4.9%),不良结局(mRS≥4)156例(95.1%),其中死亡154例(mRS 6)。
  • 108例(65.8%)在1[1-2]天内进展为脑死亡。
  • 存活者中低流量时间趋于更短、肾上腺素使用更少、瞳孔异常更少见,但未确认独立统计学关联。
  • 存活者中脑室外引流、颅内压监测和血管内动脉瘤治疗更频繁,ICU和住院时间更长。
  • 惩罚性回归未识别良好结局的独立预测因素,但瞳孔异常和肾上腺素使用与进展为脑死亡相关。

证据类型、等级与局限

  • 证据类型:回顾性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,经选择的患者可能从积极的神经重症监护中获益。
  • 高脑死亡率(65.8%在1[1-2]天内进展为脑死亡)强调了器官捐献路径的重要性。
  • 院前抗血小板或抗凝治疗患者(n=14,8.7%)均结局不良,可据此与家属沟通预后。
  • 存活者中脑室外引流、颅内压监测和血管内动脉瘤治疗更常见,但惩罚性回归未确认独立预测因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Out-of-hospital cardiac arrest (OHCA) due to aneurysmal subarachnoid hemorrhage (aSAH) is rare but associated with extremely poor prognosis. Data on neurological outcomes and prognostic factors are limited.

METHODS: We conducted a retrospective multicenter cohort study across 12 French neuro-ICUs including all adult patients admitted alive after OHCA-aSAH between 2014 and 2024. Demographics, cardiac arrest characteristics, aSAH severity, ICU management, and 6-month neurological outcomes (modified Rankin Scale, mRS) were collected. Firth penalized logistic regression was applied to explore predictors of favorable outcome.

RESULTS: Among 15,907 SAH admissions, 164 patients had OHCA-aSAH. Median age was 54 [43-62] years; 47.5% were male. Only 8 patients (4.9%) achieved favorable outcome (mRS ≤ 3) while 156 (95.1%) had poor outcome (mRS ≥ 4), including 154 deaths (mRS 6). Low-flow duration tended to be shorter, epinephrine use lower, and pupillary abnormalities less frequent among survivors, although no independent statistical association could be confirmed. All patients receiving pre-hospital antiplatelet or anticoagulant therapy (n = 14, 8.7%) had poor outcome. External ventricular drainage, ICP monitoring, and endovascular aneurysm treatment were more frequent, and ICU and hospital length of stay were longer, in survivors. One hundred and eight patients (65.8%) progressed to brain death within 1 [1-2] day. Penalized regression did not identify independent predictors of good outcome, though pupillary abnormalities and epinephrine use were associated with progression toward brain death.

CONCLUSIONS: OHCA-aSAH carries a dismal prognosis, with < 5% achieving favorable neurological recovery. Selected patients may benefit from aggressive neurocritical care, and the high rate of brain death emphasizes the importance of organ donation pathways.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Legros V, Darty F, Cateura J, et al. Neurological outcomes after out-of-hospital cardiac arrest due to aneurysmal subarachnoid hemorrhage: a multicenter cohort study. Crit Care. 2026. PMID: 42271417. doi:10.1186/s13054-026-06114-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。